Browse by author
Lookup NU author(s): Shaun Martin,
Dr David Hill,
Professor Mark Birch-MachinORCiD,
Professor Penny Lovat,
Dr Chris RedfernORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
P>Targeting endoplasmic reticulum stress-induced apoptosis may offer an alternative therapeutic strategy for metastatic melanoma. Fenretinide and bortezomib induce apoptosis of melanoma cells but their efficacy may be hindered by the unfolded protein response, which promotes survival by ameliorating endoplasmic reticulum stress. The aim of this study was to test the hypothesis that inhibition of GRP78, a vital unfolded protein response mediator, increases cell death in combination with endoplasmic reticulum stress-inducing agents. Down-regulation of GRP78 by small-interfering RNA increased fenretinide- or bortezomib-induced apoptosis. Treatment of cells with a GRP78-specific subtilase toxin produced a synergistic enhancement with fenretinide or bortezomib. These data suggest that combining endoplasmic reticulum stress-inducing agents with strategies to down-regulate GRP78, or other components of the unfolded protein response, may represent a novel therapeutic approach for metastatic melanoma.
Author(s): Martin S, Hill DS, Paton JC, Paton AW, Birch-Machin MA, Lovat PE, Redfern CPF
Publication type: Article
Publication status: Published
Journal: Pigment Cell and Melanoma Research
Print publication date: 12/07/2010
ISSN (print): 1755-1471
ISSN (electronic): 1755-148X
Altmetrics provided by Altmetric